AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MEROPENEM
79 registrations across 13 African markets— 70 active
Markets with MEROPENEM
🇺🇬Uganda
18 registrations
18 active
🇬🇭Ghana
14 registrations
12 active
🇹🇿Tanzania
12 registrations
12 active
🇿🇼Zimbabwe
9 registrations
9 active
🇸🇳Senegal
8 registrations
8 active
🇲🇼Malawi
4 registrations
0 active
🇿🇦South Africa
4 registrations
2 active
🇲🇬Madagascar
4 registrations
4 active
🇰🇪Kenya
2 registrations
2 active
🌍WW
1 registration
1 active
🇨🇮Côte d'Ivoire
1 registration
1 active
🇳🇬Nigeria
1 registration
0 active
🇿🇲Zambia
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Gebemer 1g Injection (Each Vial Contains Meropenem 1g) | 🇬🇭Ghana | — | active | Apr 2031 |
| Gebemer 1g Injection (Each Vial Contains Meropenem 1g) | 🇬🇭Ghana | — | active | Apr 2031 |
| MEROLEX 1000 POWDER FOR INJECTION | 🇬🇭Ghana | — | active | Apr 2030 |
| MEROLEX 500 POWDER FOR INJECTION | 🇬🇭Ghana | — | active | Apr 2030 |
| MEROLEX 1000 POWDER FOR INJECTION | 🇬🇭Ghana | — | active | Apr 2030 |
| MEROLEX 500 POWDER FOR INJECTION | 🇬🇭Ghana | — | active | Apr 2030 |
| MONAN POWDER; ORAL | 🇿🇼Zimbabwe | M. J. BIOPHARM (PVT) LTD | active | Aug 2029 |
| SAMERO 1 g Injection Powder for Injection | 🇿🇲Zambia | Sakar Health Care Pvt India | active | May 2029 |
| BESTINEM 1G INJECTABLE; INJECTION | 🇿🇼Zimbabwe | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | May 2029 |
| MONAN POWDER; ORAL | 🇿🇼Zimbabwe | M. J. BIOPHARM (PVT) LTD | active | Apr 2029 |
| RONEM POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Feb 2029 |
| ARCHIFAR POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MEDOCHEMIE LTD | active | Aug 2028 |
| ARCHIFAR POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MEDOCHEMIE LTD | active | Aug 2028 |
| RONEM POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Dec 2027 |
| MERIANZ 1000 POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Dec 2027 |
| MERIANZ 500 POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Dec 2027 |
| MEROPENEM INJECTION (Each vial contains Meropenem 1g) | 🇬🇭Ghana | — | active | Oct 2027 |
| MEROPENEM INJECTION (Each vial contains Meropenem 1g) | 🇬🇭Ghana | — | active | Oct 2027 |
| MERADO 500 Powder For Solution For Injection/Infusion | 🇰🇪Kenya | MEDAFRIQ PHARMA LIMITED | active | Sept 2027 |
| MERADO 1000 Powder For Solution For Injection | 🇰🇪Kenya | MEDAFRIQ PHARMA LIMITED | active | Sept 2027 |
| NOVAPENEM 500MG | 🇬🇭Ghana | PHARMANOVA LIMITED NO 3 OKODAN STREET OSU MANHEAN ACCRA GHANA | active | Sept 2026 |
| NOVAPENEM 1000MG | 🇬🇭Ghana | PHARMANOVA LIMITED NO 3 OKODAN STREET OSU MANHEAN ACCRA GHANA | active | Sept 2026 |
| NOVAPENEM 500MG | 🇬🇭Ghana | PHARMANOVA LIMITED NO 3 OKODAN STREET OSU MANHEAN ACCRA GHANA | expired | Sept 2026 |
| NOVAPENEM 1000MG | 🇬🇭Ghana | PHARMANOVA LIMITED NO 3 OKODAN STREET OSU MANHEAN ACCRA GHANA | active | Sept 2026 |
| NOVAPENEM 1000MG | 🇬🇭Ghana | PHARMANOVA LIMITED NO 3 OKODAN STREET OSU MANHEAN ACCRA GHANA | expired | Sept 2026 |
| NOVAPENEM 500MG | 🇬🇭Ghana | PHARMANOVA LIMITED NO 3 OKODAN STREET OSU MANHEAN ACCRA GHANA | active | Sept 2026 |
| RAN-MEROPENEM 500 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Jun 2025 |
| RAN-MEROPENEM 1 g | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Jun 2025 |
| SAMERO_1G 1000MG/VIAL INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| AKUMERO_1000 1000MG INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| MAXINEM_1G 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2023 |
| BOTAPEM 1000 INJECTION INJECTION 1 X 1VIAL | 🇳🇬Nigeria | ZOLON HEALTHCARE LTD 37 | expired | Oct 2021 |
| BESTINEM 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2012 |
| MERCIDE 1 g | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | active | Jan 1900 |
| MERCIDE 500 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | active | Jan 1900 |
| MERO-PLUS 1000MG POUDRE POUR SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | ATLANTA BIOLOGICAL | active | — |
| MEROPENEM PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | DAFRA PHARMA N.V/S.A | active | — |
| MEROPENEM PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | AUROBINDO PHARMA LTD | active | — |
| Meronia 500 Powder for Solution for Injection/Infusion | 🇹🇿Tanzania | Dafra Pharma GmbH | active | — |
| Maxinem Powder for solution for injection | 🇹🇿Tanzania | VHB MEDI SCIENCES LIMITED | active | — |
| MEROPENEM PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | VENUS REMIDIES LTD | active | — |
| Merogram 1000 Powder for solution for injection | 🇹🇿Tanzania | Eugia Pharma Specialities Limited | active | — |
| MPEN poudre injectable / 1000 mg | 🇸🇳Senegal | BRAWN LABORATORIES LTD | active | — |
| ZAXTER SUSPENSION INJECTABLE / 1000mg | 🇸🇳Senegal | ALKEM | active | — |
| ZAXTER solution injectable / 1 g | 🇸🇳Senegal | ALKEM | active | — |
| NURONEM solution injectable / 500mg/1000mg | 🇸🇳Senegal | SUN PHARMACEUTICAL | active | — |
| MERONIA® 1000 IV PDRE PSI IV OU PERF BTE (1 FL) DAFRA PHARMA poudre pour 30ml de solution | 🇲🇬Madagascar | DAFRA PHARMA GmbH | active | — |
| MERONIA® 500 IV PDRE PSI IV OU PERF BTE (1 FL) DAFRA PHARMA poudre pour 20ml de solution | 🇲🇬Madagascar | DAFRA PHARMA GmbH | active | — |
| ZAXTER 1 G Powder for Injection | 🇹🇿Tanzania | Alkem Laboratories Limited | active | — |
| MERONIA® 1000 IV PDRE PSI IV OU PERF BTE (1 FL) DAFRA PHARMA poudre pour 30ml de solution | 🇲🇬Madagascar | DAFRA PHARMA GmbH | active | — |
Showing 50 of 79 registrations. Sign up free to search and export all.
MEROPENEM in Africa — Regulatory Overview
MEROPENEM is registered across 13 African markets with 79 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Ghana, Tanzania, Zimbabwe and 9 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 79 registrations, 70 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.